None listed
Conditions
Interventions
Group 1: The project is a multicenter, prospective care study at the university hospitals of Tübingen, Freiburg, Ulm, and Heidelberg. The study design follows the Hybrid III approach according to Curr
Sponsors
Insitut für Allgemeinmedizin und interprofessionelle Versorgung, Universitätsklinikum Tübingen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (Suspected) post-acute infection syndrome (e.g., PCS, ME/CFS, post-VAC); Duration of illness of at least 6 months; Functional limitations with a PCFS score = 3; Residence in Baden-Württemberg or a district bordering BW; Capacity to consent and consent to participate in the study; Insurance under statutory health insurance;
Exclusion criteria
Exclusion criteria: Inability to visit a SPVP OR attend a video consultation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the change in perceived quality of care and symptom severity. Perceived quality of care is assessed using the PACIC-S (Patient Assessment of Chronic Illness Care – Short Form) and is measured at study entry/baseline (T0), after 3 months or at the last CCM contact (T1), and at 12 months (T3). Symptom severity is assessed using the PCS score (Post-COVID Syndrome Score) and is measured at baseline (T0) and at 12 months (T3). Change is defined as the difference in total scores between the respective assessment time points (PACIC-S: T0–T1 and T0–T3; PCS: T0–T3). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints include health-related quality of life assessed with the EQ-5D-5L (EuroQol 5-Dimension, 5-Level), self-efficacy measured using the SES6G (Self-Efficacy for Managing Chronic Disease—6-Item Scale), recovery following illness assessed with the Recovery measure, and functional impairment measured with the Bell Score (Bell Disability Scale). All secondary endpoints are assessed at each measurement time point: baseline (T0), after 3 months or at the last CCM contact (T1), after 6 months (T2), and after 12 months (T3). | — |
Countries
Germany
Outcome results
None listed